Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Aug 27;8(16):4476-4477.
doi: 10.1182/bloodadvances.2024013429.

Metformin for MPN: teaching an old drug new tricks

Affiliations
Comment

Metformin for MPN: teaching an old drug new tricks

Michelle H Lee et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: G.S.H. receives consultancy from AbbVie, Pfizer, Incyte, Novartis, GlaxoSmithKline, PharmaEssentia, and Bristol Myers Squibb, and reports spouse employment at Regeneron Genetics Center. M.L. declares no competing financial interests.

Comment on

References

    1. Kristensen DT, Øvlisen AK, Jakobsen LH, et al. Metformin use and risk of myeloproliferative neoplasms - a Danish population-based case-control study. Blood Adv. 2024;8(16):4478–4485. - PMC - PubMed
    1. Mendez Luque LF, Blackmon AL, Ramanathan G, Fleischman AG. Key role of inflammation in myeloproliferative neoplasms: instigator of disease initiation, progression and symptoms. Curr Hematol Malig Rep. 2019;14(3):145–153. - PMC - PubMed
    1. Bailey CJ. Metformin: historical overview. Diabetologia. 2017;60(9):1566–1576. - PubMed
    1. Abdallah M, Dumontier C, Orkaby A, et al. Metformin use and incidence of cancer: a large retrospective cohort study of U.S. Veterans. Blood. 2022;140(suppl 1):10991–10992.
    1. Machado-Neto JA, Fenerich BA, Scopim-Ribeiro R, et al. Metformin exerts multitarget antileukemia activity in JAK2(V617F)-positive myeloproliferative neoplasms. Cell Death Dis. 2018;9(3):311. - PMC - PubMed

MeSH terms